Genetic influences in the variation in renal clearance of nicotine and cotinine

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 2, 2008, Pages 243-247

  Benowitz, N L ^a,b   Lessov Schlaggar, C N ^c   Swan, G E ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

ADULT; ARTICLE; BIOMETRY; CREATININE CLEARANCE; DIZYGOTIC TWINS; DRUG CLEARANCE; ENVIRONMENTAL FACTOR; FEMALE; GENETIC SELECTION; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HERITABILITY; HUMAN; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EXCRETION; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; PH MEASUREMENT; PRIORITY JOURNAL; SMOKING; URINE PH;

ADULT; BIOLOGICAL TRANSPORT, ACTIVE; COTININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NICOTINE; SMOKING; TWINS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; VARIATION (GENETICS);

EID: 49149095103     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.54     Document Type: Article

References (14)

1. Benowitz, N.L. & Jacob, P. 3rd. Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J. Pharmacol. Exp. Ther. 234, 153-155 (1985).
2. Weber, W. Pharmacogenetics (Oxford Univ. Press, New York, 1997).
3. Leabman, M.K. et al. Heritability of metformin renal clearance. Clin. Pharmacol. Ther. 77, P61 (2005).
4. Leabman, M.K. & Giacomini, K.M. Estimating the contribution of genes and environment to variation in renal drug clearance. Pharmacogenetics 13, 581-584 (2003).
5. Swan, G.E. et al. Pharmacogenetics of nicotine metabolism in twins: methods and procedures. Twin Res. 7, 435-448 (2004).
6. Swan, G.E., Benowitz, N.L., Lessov, C.N., Jacob, P. 3rd, Tyndale, R.F. & Wilhelmsen, K. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenet. Genomics 15, 115-125 (2005).
7. Hukkanen, J., Jacob, P. 3rd & Benowitz, N.L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 57, 79-115 (2005).
8. Elwi, A.N., Damaraju, V.L., Baldwin, S.A., Young, J.D., Sawyer, M.B. & Cass, C.E. Renal nucleoside transporters: physiological and clinical implications. Biochem. Cell Biol. 84, 844-858 (2006).
9. Zevin, S., Schaner, M.E. & Giacomini, K.M. Nicotine transport in a human choriocarcinoma cell line (JAR). J. Pharm. Sci. 87, 702-706 (1998).
10. Benowitz, N.L., Kuyt, F., Jacob, P. 3rd, Jones, R.T. & Osman, A.L. Cotinine disposition and effects. Clin. Pharmacol. Ther. 34, 604-611 (1983).
11. Fox, C.S. et al. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. J. Am. Soc. Nephrol. 15, 2457-2461 (2004).
12. Hunt, S.C. et al. Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees. Am. J. Hypertens. 17, 511-515 (2004).
13. Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. & Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 130, 461-470 (1999).
14. Neale, M.C., Boker, S.M., Xie, G. & Maes, H.H. Mx: Statistical Modeling, 6th edn. (Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, 2002).